A cross-sectional study to estimate high-risk human papillomavirus prevalence and type distribution in Italian women aged 18–26 years

Table 3 Distribution of HPV genotypes in HR-HC2 test positive women and overall population

HPV genotypes	Number of infections	HR-HC2 test positive women (N = 194), %	Overall population* (N = 1094), %
16	60	30.9	5.5
31	38	19.6	3.5
66**	25	12.9	2.3
51	22	11.3	2.0
18	17	8.8	1.6
56	17	8.8	1.6
58	16	8.3	1.5
59	10	5.2	0.9
52	9	4.6	0.8
39	9	4.6	0.8
45	8	4.1	0.7
53**	7	3.6	0.6
33	6	3.1	0.5
68	6	3.1	0.5
73**	3	1.5	0.3
35	2	1.0	0.2
82**	1	0.5	0.1
26**	0	0.0	0.0

* HPV type-specific prevalence has been extrapolated to overall population although it should be stressed that the genotyping was performed only on HR-HC2 positive samples.
** The prevalence of HPV 26,53,66,73,82 is probably underestimated because these HPV types are detected by the “Consensus High Risk HPV genotyping” assay, but they are not targeted by the HR-HC2 test.

ISSN: 1471-2334